Perrigo Company
1887
FOUNDED
PUBLIC
STATUS
10K-15K
EMPLOYEES
PRGO
STOCK SYMBOL
37
INVESTMENTS
$72.75
SHARE PRICE
(As of Tuesday Closing)
Description
Manufacturer of over the counter healthcare products and supplier of infant formulas for the store brand market. The company focuses on providing value to its customers and consumers by delivering quality affordable healthcare products.
Primary Industry
Pharmaceuticals
Stock Exchange
NYS
Primary Office
- Treasury Building
- Lower Grand Canal Street
- Dublin 2
- Ireland
+353 (01) 000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Perrigo Company’s full profile, request a free trial.
Perrigo Company Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $69.44 - $95.15 | $9.6B | $71.82 | $1.66 | 1.5M | 137M |
Perrigo Company Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
FY 2015
30-Jun-2015
|
|---|---|---|---|---|
| Enterprise Value | 12,746,773 | 15,192,677 | 11,933,054 | 28,226,229 |
| Revenue | 4,917,800 | 4,946,200 | 5,280,600 | 4,227,100 |
| EBITDA | 1,001,400 | 893,000 | (4,174,700) | 665,000 |
| Net Income | 234,700 | 119,600 | (4,012,800) | 136,100 |
| Total Assets | 11,225,600 | 11,628,800 | 13,870,100 | 19,591,900 |
| Total Debt | 3,283,000 | 3,341,200 | 5,797,300 | 5,400,200 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Perrigo Company Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Perrigo Company‘s full profile, request access.
Request full access to PitchBookPerrigo Company Investments & Acquisitions (37)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 000000000000 | 27-Apr-2018 | 000000000 00000 00 | Buildings and Property | ||
| 00000, 000000 & 00 | 17-Aug-2016 | 000000000000000000 | Personal Products | 0000 00000000000 | |
| 0000000 0000000000 | 25-Jan-2016 | 000000000000000000 | 00000 | Pharmaceuticals | 000000 0000 |
| 00000000 000000 (0 | 31-Dec-2015 | 000000000 00000 00 | 00000 | Pharmaceuticals | 000000 0000 |
| Naturwohl Pharma | 15-Sep-2015 | Merger/Acquisition | 00000 | Distributors/Wholesale | 000000 0000 |
Perrigo Company Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000 0000000000 | 01-Jan-2003 | 000000000000000000 | Completed |
|
|
| Vi-Jon | 01-Dec-1994 | Merger/Acquisition | 0000 | Completed |
Perrigo Company Subsidiaries (6)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Vedants Drugs and Fine Chemicals | Pharmaceuticals | Mumbai, India | 2004 |
| 00000, 000000 & 00 | Personal Products | Peachtree City, GA | 0000 |
| 00000 000000 | Personal Products | Nazareth, Belgium | 0000 |
| 0000000 000000000 | Pharmaceuticals | Balcatta, Australia | 0000 |
| 0000000 0000000000 | Drug Delivery | Ciudad Satélite, Mexico | 0000 |
Perrigo Company Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Perrigo Company‘s full profile, request access.
Request full access to PitchBookPerrigo Company Executive Team (22)
12 Former Executives
You’re viewing 5 of 22 executives. Get the full list »